Published in Cancer Weekly, August 31st, 2010
While Exact does not have any immediate plans to offer securities under this shelf registration, it is intended to give the company the flexibility to take advantage of financing opportunities as needed or deemed desirable in light of market or other conditions.
The registration statement has been filed with the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.